1. Home
  2. SPRY vs IGIC Comparison

SPRY vs IGIC Comparison

Compare SPRY & IGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • IGIC
  • Stock Information
  • Founded
  • SPRY 2015
  • IGIC 2001
  • Country
  • SPRY United States
  • IGIC Jordan
  • Employees
  • SPRY N/A
  • IGIC N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • IGIC Property-Casualty Insurers
  • Sector
  • SPRY Health Care
  • IGIC Finance
  • Exchange
  • SPRY Nasdaq
  • IGIC Nasdaq
  • Market Cap
  • SPRY 1.4B
  • IGIC 1.1B
  • IPO Year
  • SPRY N/A
  • IGIC N/A
  • Fundamental
  • Price
  • SPRY $11.41
  • IGIC $24.17
  • Analyst Decision
  • SPRY Strong Buy
  • IGIC Buy
  • Analyst Count
  • SPRY 4
  • IGIC 3
  • Target Price
  • SPRY $24.00
  • IGIC $23.67
  • AVG Volume (30 Days)
  • SPRY 959.4K
  • IGIC 119.6K
  • Earning Date
  • SPRY 11-13-2024
  • IGIC 11-05-2024
  • Dividend Yield
  • SPRY N/A
  • IGIC 2.40%
  • EPS Growth
  • SPRY N/A
  • IGIC 32.83
  • EPS
  • SPRY N/A
  • IGIC 3.04
  • Revenue
  • SPRY $2,568,000.00
  • IGIC $506,160,000.00
  • Revenue This Year
  • SPRY $95,526.66
  • IGIC N/A
  • Revenue Next Year
  • SPRY $275.98
  • IGIC $6.64
  • P/E Ratio
  • SPRY N/A
  • IGIC $7.91
  • Revenue Growth
  • SPRY 8460.00
  • IGIC 10.67
  • 52 Week Low
  • SPRY $5.02
  • IGIC $11.51
  • 52 Week High
  • SPRY $18.51
  • IGIC $27.00
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 32.88
  • IGIC 46.72
  • Support Level
  • SPRY $11.76
  • IGIC $23.60
  • Resistance Level
  • SPRY $14.50
  • IGIC $24.72
  • Average True Range (ATR)
  • SPRY 0.75
  • IGIC 0.73
  • MACD
  • SPRY -0.20
  • IGIC -0.37
  • Stochastic Oscillator
  • SPRY 1.63
  • IGIC 15.83

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

Share on Social Networks: